Glaucoma Risk with Metformin and Sulfonylurea Therapies in Type 2 Diabetes: A Retrospective Cohort Study.

Clin Ophthalmol · 2026 · PMC13016381 · PMID 41891096

Europe PMC DOI

hedged sentence

0.1440

closest p · 2.9× alpha

0.1440

boldest claim

The sentences

did not reach statistical significancep=0.144not close (p > 0.1)

Direct comparison between combination therapy and metformin monotherapy did not reach statistical significance (adjusted HR 1.084, 95% CI 0.973–1.207, p=0.144).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.